358 related articles for article (PubMed ID: 15370119)
1. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.
Cochran AJ; Roberts A; Wen DR; Huang RR; Itakura E; Luo F; Binder SW
Pathology; 2004 Oct; 36(5):478-84. PubMed ID: 15370119
[TBL] [Abstract][Full Text] [Related]
2. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska GuimarĂ£es CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
5. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
6. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
7. Pathobiology of the sentinel node.
Cochran AJ; Ohsie SJ; Binder SW
Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
[TBL] [Abstract][Full Text] [Related]
8. The detection and significance of melanoma micrometastases in sentinel nodes.
Scolyer RA; Murali R; Satzger I; Thompson JF
Surg Oncol; 2008 Sep; 17(3):165-74. PubMed ID: 18639451
[TBL] [Abstract][Full Text] [Related]
9. Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).
Stitzenberg KB; Groben PA; Stern SL; Thomas NE; Hensing TA; Sansbury LB; Ollila DW
Ann Surg Oncol; 2004 Oct; 11(10):900-6. PubMed ID: 15383424
[TBL] [Abstract][Full Text] [Related]
10. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
11. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
[TBL] [Abstract][Full Text] [Related]
12. No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load.
Bogenrieder T; van Dijk MR; Blokx WA; Ramrath K; Seldenrijk K; Stolz W; van Diest PJ
Histopathology; 2011 Aug; 59(2):318-26. PubMed ID: 21884211
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
14. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
Faries MB; Bleicher RJ; Ye X; Essner R; Morton DL
Arch Surg; 2004 Aug; 139(8):870-6; discussion 876-7. PubMed ID: 15302697
[TBL] [Abstract][Full Text] [Related]
16. Detection of melanoma micrometastases in sentinel nodes - the cons.
de Wilt JH; van Akkooi AC; Verhoef C; Eggermont AM
Surg Oncol; 2008 Sep; 17(3):175-81. PubMed ID: 18617395
[TBL] [Abstract][Full Text] [Related]
17. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
Dewar DJ; Newell B; Green MA; Topping AP; Powell BW; Cook MG
J Clin Oncol; 2004 Aug; 22(16):3345-9. PubMed ID: 15310779
[TBL] [Abstract][Full Text] [Related]
18. [Sentinel node biopsy in melanoma: some critical questions].
Nieweg OE; Eggermont AM; Kroon BB
Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1774-7. PubMed ID: 12369437
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group.
Gipponi M; Solari N; Lionetto R; Di Somma C; Villa G; Schenone F; Queirolo P; Cafiero F
Eur J Surg Oncol; 2005 Dec; 31(10):1191-7. PubMed ID: 15894454
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
Wilson LL
Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]